Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (2572)	7/20/2001 7:29:49 PM
From: keokalani'nui	of 4974

Thursday July 19, 9:26 am Eastern Time DNA Sciences withdraws plans for $125 mln IPO WASHINGTON, July 19 (Reuters) - DNA Sciences Inc., a genetics discovery company that examines the role that genes play in diseases like cancer, osteoporosis and diabetes, on Thursday withdrew plans for a $125 million initial stock offering. The Fremont, California-based company, whose backers include international financier George Soros's Quantum Partners fund and online health information provider WebMD Corp. (NasdaqNM:HLTH - news), had not yet determined the size and price of the initial public offering. ``The registrant desires to withdraw the registration statement due to changes in the registrant's business and financing plans, recent market volatility and other considerations,'' the company said in a filing with the U.S. Securities and Exchange Commission. The underwriters were Lehman Brothers, CIBC World Markets and Dain Rauscher Wessels. It was looking to trade its shares on Nasdaq under the symbol ``DNAS''

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next